electroCore, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $89.3M
- Price
- $9.88
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.65%
- Volume
- 6.8K
About
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Quick stats
Shares outstanding9.0M
Computed float8.2M
Float / shares90.2%
Cash runway (months)5.3
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001560258
Websitehttps://www.electrocore.com
AI Summary
AI-generated1/27
minorneutralother
electroCore to Participate at H.C. Wainwright Global Investment Conference
electroCore will participate in the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel.
On Tuesday, September 15, 2026, Co-CEO, President and CFO Joshua Lev will join a fireside chat and host one-on-one meetings with investors during the conference.
The appearance is routine investor outreach with no new financial or clinical disclosure; investors can request meetings through H.C. Wainwright or electroCore Investor Relations.